Application of next-generation imaging in biochemically recurrent prostate cancer.

ABSTRACT:

Background

Biochemical recurrence (BCR) following primary interventional treatment occurs in approximately one-third of patients with prostate cancer (PCa). Next-generation imaging (NGI) can identify local and metastatic recurrence with greater sensitivity than conventional imaging, potentially allowing for more effective interventions. This narrative review examines the current clinical evidence on the utility of NGI for patients with BCR.

Methods

A search of PubMed was conducted to identify relevant publications on NGI applied to BCR. Given other relevant recent reviews on the topic, this review focused on papers published between January 2018 to May 2023.

Results

NGI technologies, including positron emission tomography (PET) radiotracers and multiparametric magneti

SUBMITTER: Moul JW 

PROVIDER: S-EPMC11096127 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature